Filing Details

Accession Number:
0001645113-20-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-28 16:41:38
Reporting Period:
2020-02-25
Accepted Time:
2020-02-28 16:41:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645113 Novocure Ltd NVCR Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744884 Pritesh Shah C/O Novocure Inc.,
20 Valley Stream Parkway, Suite 300
Malvern PA 19355
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2020-02-25 5,067 $81.16 75,653 No 4 S Direct
Ordinary Shares Disposition 2020-02-26 2,100 $78.68 73,553 No 4 S Direct
Ordinary Shares Disposition 2020-02-26 4,332 $79.45 69,221 No 4 S Direct
Ordinary Shares Disposition 2020-02-26 1,500 $80.22 67,721 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.
  2. On February 26, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 2100 shares in multiple trades at prices ranging from $77.97 to $78.94. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
  3. On February 26, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 4332 shares in multiple trades at prices ranging from $79.00 to $79.99. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
  4. On February 26, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 1500 shares in multiple trades at prices ranging from $80.01 to $80.51. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.